BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zagzoog A, Mohamed KA, Kim HJJ, Kim ED, Frank CS, Black T, Jadhav PD, Holbrook LA, Laprairie RB. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Sci Rep 2020;10:20405. [PMID: 33230154 DOI: 10.1038/s41598-020-77175-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zagzoog A, Cabecinha A, Abramovici H, Laprairie RB. Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules. Front Pharmacol 2022;13:956030. [DOI: 10.3389/fphar.2022.956030] [Reference Citation Analysis]
2 Przybycień P, Gąsior-perczak D, Placha W. Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility. Cells 2022;11:2569. [DOI: 10.3390/cells11162569] [Reference Citation Analysis]
3 Jastrząb A, Jarocka-karpowicz I, Skrzydlewska E. The Origin and Biomedical Relevance of Cannabigerol. IJMS 2022;23:7929. [DOI: 10.3390/ijms23147929] [Reference Citation Analysis]
4 Gado F, Ferrisi R, Polini B, Mohamed KA, Ricardi C, Lucarini E, Carpi S, Domenichini F, Stevenson LA, Rapposelli S, Saccomanni G, Nieri P, Ortore G, Pertwee RG, Ghelardini C, Di Cesare Mannelli L, Chiellini G, Laprairie RB, Manera C. Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands. J Med Chem 2022. [PMID: 35849804 DOI: 10.1021/acs.jmedchem.2c00582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ceni C, Benko MJ, Mohamed KA, Poli G, Di Stefano M, Tuccinardi T, Digiacomo M, Valoti M, Laprairie RB, Macchia M, Bertini S. Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold. Pharmaceuticals 2022;15:768. [DOI: 10.3390/ph15070768] [Reference Citation Analysis]
6 Welling MT, Deseo MA, Bacic A, Doblin MS. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review. Phytochemistry 2022;201:113282. [PMID: 35718133 DOI: 10.1016/j.phytochem.2022.113282] [Reference Citation Analysis]
7 Kim HJJ, Zagzoog A, Black T, Baccetto SL, Ezeaka UC, Laprairie RB. Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes. Pharmacol Res Perspect 2022;10:e00950. [PMID: 35466560 DOI: 10.1002/prp2.950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Manca A, Palermiti A, Mula J, De Vivo ED, Zeaiter S, Simiele M, De Nicolò A, Cantù M, Cusato J, D'Avolio A. A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. Phytomedicine 2022;102:154218. [PMID: 35665680 DOI: 10.1016/j.phymed.2022.154218] [Reference Citation Analysis]
9 Di Meo C, Tortolani D, Standoli S, Angelucci CB, Fanti F, Leuti A, Sergi M, Kadhim S, Hsu E, Rapino C, Maccarrone M. Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. Int J Mol Sci 2022;23:5430. [PMID: 35628241 DOI: 10.3390/ijms23105430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Vernail VL, Bingaman SS, Silberman Y, Raup-konsavage WM, Vrana KE, Arnold AC. Acute Cannabigerol Administration Lowers Blood Pressure in Mice. Front Physiol 2022;13:871962. [DOI: 10.3389/fphys.2022.871962] [Reference Citation Analysis]
11 Gheasuddin Y, Galea GL. Cannabidiol impairs neural tube closure in mouse whole embryo culture. Birth Defects Res 2022. [PMID: 35416425 DOI: 10.1002/bdr2.2013] [Reference Citation Analysis]
12 Wang B, Li D, Fiselier A, Kovalchuk I, Kovalchuk O. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00876-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Russo F, Tolomeo F, Vandelli MA, Biagini G, Paris R, Fulvio F, Laganà A, Capriotti AL, Carbone L, Gigli G, Cannazza G, Citti C. Kynurenine and kynurenic acid: Two human neuromodulators found in Cannabis sativa L. Journal of Pharmaceutical and Biomedical Analysis 2022;211:114636. [DOI: 10.1016/j.jpba.2022.114636] [Reference Citation Analysis]
15 Morales P, Muller C, Jagerovic N, Reggio PH. Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators. Front Mol Biosci 2022;9:841190. [DOI: 10.3389/fmolb.2022.841190] [Reference Citation Analysis]
16 Kim HJJ, Zagzoog A, Smolyakova AM, Ezeaka UC, Benko MJ, Holt T, Laprairie RB. In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors. Front Neurosci 2021;15:790546. [PMID: 34992518 DOI: 10.3389/fnins.2021.790546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Dalle S, Schouten M, Koppo K. Letter to the Editor: The Receptor(s) via Which Cannabidiol Affects Muscle Signaling: In Need for More Insights. Cannabis Cannabinoid Res 2021. [PMID: 34978895 DOI: 10.1089/can.2021.0210] [Reference Citation Analysis]
18 Lee YE, Nakashima Y, Kodama T, Chen X, Morita H. Dual Engineering of Olivetolic Acid Cyclase and Tetraketide Synthase to Generate Longer Alkyl-Chain Olivetolic Acid Analogs. Org Lett 2021. [PMID: 34939812 DOI: 10.1021/acs.orglett.1c04089] [Reference Citation Analysis]
19 Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol 2021;12:777804. [PMID: 34916950 DOI: 10.3389/fphar.2021.777804] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Anand U, Oldfield C, Pacchetti B, Anand P, Sodergren MH. Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons. J Pain Res 2021;14:3603-14. [PMID: 34853533 DOI: 10.2147/JPR.S336773] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Chen X, Deng H, Heise JA, Puthoff DP, Bou-Abboud N, Yu H, Peng J. Contents of Cannabinoids in Hemp Varieties Grown in Maryland. ACS Omega 2021;6:32186-97. [PMID: 34870039 DOI: 10.1021/acsomega.1c04992] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. J Natl Cancer Inst Monogr 2021;2021:86-98. [PMID: 34850897 DOI: 10.1093/jncimonographs/lgab011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Rømer Thomsen K, Thylstrup B, Kenyon EA, Lees R, Baandrup L, Feldstein Ewing SW, Freeman TP. Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth? Neurosci Biobehav Rev 2021;132:169-80. [PMID: 34822876 DOI: 10.1016/j.neubiorev.2021.11.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Greis A, Larsen E, Liu C, Renslo B, Radakrishnan A, Wilson-Poe AR. Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain. Cannabis Cannabinoid Res 2021. [PMID: 34767730 DOI: 10.1089/can.2021.0088] [Reference Citation Analysis]
25 Filipiuc LE, Ababei DC, Alexa-Stratulat T, Pricope CV, Bild V, Stefanescu R, Stanciu GD, Tamba BI. Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? Pharmaceutics 2021;13:1823. [PMID: 34834237 DOI: 10.3390/pharmaceutics13111823] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
26 Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis Cannabinoid Res 2021. [PMID: 34569849 DOI: 10.1089/can.2021.0058] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Mnekin L, Ripoll L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021;8:85. [DOI: 10.3390/cosmetics8030085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
28 Zhou C, Assareh N, Arnold JC. The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice. Cannabis Cannabinoid Res 2021. [PMID: 34182770 DOI: 10.1089/can.2021.0027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zagzoog A, Brandt AL, Black T, Kim ED, Burkart R, Patel M, Jin Z, Nikolaeva M, Laprairie RB. Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor. Sci Rep 2021;11:10611. [PMID: 34012003 DOI: 10.1038/s41598-021-90167-w] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
30 Zamberletti E, Rubino T, Parolaro D. Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacol Ther 2021;226:107878. [PMID: 33895189 DOI: 10.1016/j.pharmthera.2021.107878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
31 Oultram JMJ, Pegler JL, Bowser TA, Ney LJ, Eamens AL, Grof CPL. Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines 2021;9:234. [PMID: 33652704 DOI: 10.3390/biomedicines9030234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Jenkins BW, Khokhar JY. Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models. Front Psychiatry 2021;12:597725. [PMID: 33613338 DOI: 10.3389/fpsyt.2021.597725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Criscuolo E, De Sciscio ML, Fezza F, Maccarrone M. In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors. Molecules 2020;26:E48. [PMID: 33374180 DOI: 10.3390/molecules26010048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]